A twist of FATe: Lipid droplets and inflammatory lipid mediators.


Journal

Biochimie
ISSN: 1638-6183
Titre abrégé: Biochimie
Pays: France
ID NLM: 1264604

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 17 06 2019
accepted: 25 11 2019
pubmed: 2 12 2019
medline: 26 9 2020
entrez: 2 12 2019
Statut: ppublish

Résumé

Lipid droplets are fat storage organelles present in most eukaryotic cells. They consist of a neutral lipid core containing mostly triglycerides and sterol esters and covered by a monolayer of phospholipids, wherein numerous proteins are embedded. In the cell, lipid droplets have a dynamic life cycle, rapidly altering their size, location, lipid and protein composition in response to environmental stimuli and cell state. Lipid droplets are primarily involved in the coordination of lipid metabolism with cellular requirements for energy production, membrane homeostasis and cell growth. However, they are also directly or indirectly engaged in signalling pathways. On the one hand, lipid droplets sequester lipids and proteins thereby limiting their availability for participation in signalling pathways. On the other hand, the lipolytic machinery provides a highly regulated, on-demand source of signalling lipids: lipids derived from their neutral lipid core, or the phospholipid monolayer, directly act as signalling mediators or are converted into ones. In fact, emerging studies suggest that these organelles are essential for various cellular stress response mechanisms, including inflammation and immunity, acting as hubs that integrate metabolic and inflammatory processes. Here, we discuss the ways in which lipid droplets regulate the availability of fatty acids for the activation of signalling pathways and for the production of polyunsaturated fatty acid-derived lipid mediators. We focus in particular on recent discoveries in immune cells and adipose tissue that have revealed an intricate relationship between lipid droplets and inflammatory signalling and may also be relevant for other tissues and various human diseases.

Identifiants

pubmed: 31786231
pii: S0300-9084(19)30339-6
doi: 10.1016/j.biochi.2019.11.016
pii:
doi:

Substances chimiques

Eicosanoids 0
Phospholipids 0
Toll-Like Receptors 0
Triglycerides 0
Docosahexaenoic Acids 25167-62-8
Phospholipases EC 3.1.-
Lipase EC 3.1.1.3
PNPLA2 protein, human EC 3.1.1.3

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-87

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Eva Jarc (E)

Department of Molecular and Biomedical Sciences, Jožef Stefan Institute, Jamova cesta 39, Ljubljana, SI-1000, Slovenia; Jožef Stefan International Postgraduate School, Jamova cesta 39, Ljubljana, SI-1000, Slovenia. Electronic address: eva.jarc@ijs.si.

Toni Petan (T)

Department of Molecular and Biomedical Sciences, Jožef Stefan Institute, Jamova cesta 39, Ljubljana, SI-1000, Slovenia. Electronic address: toni.petan@ijs.si.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH